SCHEMBL23816596

SCHEMBL23816596

CC(C)(C)c1oc2ccccc2c(=O)c1O

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 9/20 0.57
CYP3A4 P08684 8/20 0.57
HSD17B10 Q99714 7/20 0.57
ALDH1A1 P00352 6/20 0.57
MAOA P21397 5/20 0.57
HPGD P15428 5/20 0.57
MAPT P10636 4/20 0.57
CASP1 P29466 3/20 0.57
CASP7 P55210 3/20 0.57
SMN1; SMN2 Q16637 2/20 0.57
GLA P06280 1/20 0.57
PGAM1 P18669 1/20 0.57
MEN1 O00255 7/20 0.54
KMT2A Q03164 7/20 0.54
TP53 P04637 4/20 0.54
MAPK1 P28482 4/20 0.54
LMNA P02545 3/20 0.54
ALOX15 P16050 3/20 0.54
CA12 O43570 1/20 0.54
CA1 P00915 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14506245 0.81 MAOA (0.59) KDM4ECYP3A4HSD17B10ALDH1A1MAOA
SCHEMBL27401495 0.81 MAOA (0.59) KDM4ECYP3A4HSD17B10ALDH1A1MAOA
SCHEMBL20837497 0.79 CYP3A4 (0.50) KDM4ECYP3A4HSD17B10ALDH1A1MAOA
Xanthone SCHEMBL11245548 0.77 MAOA (0.86) KDM4ECYP3A4HSD17B10ALDH1A1MAOA
SCHEMBL4757017 0.77 LMNA (0.61) KDM4ECYP3A4HSD17B10ALDH1A1MAOA
SCHEMBL1180659 0.76 KDM4E (0.62) KDM4ECYP3A4HSD17B10ALDH1A1MAOA
SCHEMBL31566133 0.75 TP53 (0.72) KDM4ECYP3A4HSD17B10ALDH1A1HPGD
Xanthone SCHEMBL29398266 0.74 MAOA (1.00) KDM4ECYP3A4HSD17B10ALDH1A1MAOA
Xanthone SCHEMBL29358061 0.74 MAOA (1.00) KDM4ECYP3A4HSD17B10ALDH1A1MAOA
SCHEMBL4696277 0.74 MAOA (0.90) KDM4ECYP3A4HSD17B10ALDH1A1MAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210284622-A1 BIOACTIVE POLYMERS WITH ANTI=FOULING PROPERTIES FOR MEDICAL AND DENTAL USES NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2021-09-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210284622-A1 BIOACTIVE POLYMERS WITH ANTI=FOULING PROPERTIES FOR MEDICAL AND DENTAL USES FGB, FIBP, DDOST KDM4E 3863/4885CYP3A4 4714/4885HSD17B10 3884/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.